Is a complete NVNO research report available?

No complete published report is available for enVVeno Medical Corporation (NVNO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · USD

$6.85

+0.11 (+1.6%)· Recorded snapshot

Market cap	4.7M
Net income (ttm)	-15.7M
EPS (ttm)	-$24.9
Shares out	682.7K
Volume	45,154
Beta	1.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -15.7M
EPS (ttm): -$24.9
Market cap: 4.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001661053
Company name	enVVeno Medical Corporation
Country	United States
Country code	US
CUSIP number	29415J205
Earnings date	2026-11-10
Earnings time	bmo
Employees	33
Employees change	-4
Employees growth	-10.81%
Enterprise value	$-16.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US29415J2050
Last 10-K release date	2026-03-26
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2026-01-20
Last stock split type	Reverse
Market cap	$4.7M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$6.85
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	NVNO
U.S. state	California
Website	https://www.envveno.com

Metric

Value

Amount currency

USD

CIK code

0001661053

Company name

enVVeno Medical Corporation

Country

United States

Country code

CUSIP number

29415J205

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

-4

Employees growth

-10.81%

Enterprise value

$-16.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1987

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US29415J2050

Last 10-K release date

2026-03-26

Last earnings date

2026-07-31

Last refreshed

2026-10-28

Last stock split date

2026-01-20

Last stock split type

Reverse

Market cap

$4.7M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$6.85

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

NVNO

U.S. state

California

Website

https://www.envveno.com

Metric	Value
Earnings yield	-363.5%
FCF / EV yield	89.05%
FCF yield	-320.62%
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	0.22x
Price / tangible book value	0.22x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-363.5%

FCF / EV yield

89.05%

FCF yield

-320.62%

Industry forward P/E

19.81x

Industry P/E

39.28x

P/B ratio

0.22x

Price / tangible book value

0.22x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-476,485
ROA	-36.67%
ROA (5Y)	-32.83%
ROCE	-83.67%
ROE	-58.53%
ROE (5Y)	-53.54%
ROIC	-39.42%

Metric

Value

Profit per employee

$-476,485

ROA

-36.67%

ROA (5Y)

-32.83%

ROCE

-83.67%

ROE

-58.53%

ROE (5Y)

-53.54%

ROIC

-39.42%

Metric	Value
EPS growth quarters	4
EPS growth years	3
Net income growth quarters	4
Net income growth years	3
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$124,000
EBIT	$-17.4M
EBITDA	$-17.3M
EPS	$-24.90
FCF per share	$-21.42
Financing cash flow	$1.1M
Free cash flow	$-14.6M
Free cash flow minus SBC	$-16.8M
Investing cash flow	$14.3M
Net cash flow	$797,000
Net income	$-15.7M
Operating cash flow minus SBC	$-16.8M
Operating income	$-17.4M
Stock-based compensation	$2.2M

Metric

Value

Capital expenditures

Depreciation and amortization

$124,000

EBIT

$-17.4M

EBITDA

$-17.3M

EPS

$-24.90

FCF per share

$-21.42

Financing cash flow

$1.1M

Free cash flow

$-14.6M

Free cash flow minus SBC

$-16.8M

Investing cash flow

$14.3M

Net cash flow

$797,000

Net income

$-15.7M

Operating cash flow minus SBC

$-16.8M

Operating income

$-17.4M

Stock-based compensation

$2.2M

Metric	Value
Book value per share	$30.71
Debt / equity	0.02
Long-term assets	$578,000
Long-term liabilities	$103,000
Net cash (debt)	$21M
Net cash / market cap	460.05%
Net cash growth	-38.76%
Net debt / equity	-1.02
Piotroski F-Score	1
Property, plant and equipment	$547,000
Shareholders' equity	$20.7M
Tangible book value	$20.7M
Tangible book value per share	$30.71
Total assets	$22.7M
Total cash	$21.5M
Total debt	$505,000
Total liabilities	$2M
WACC	10.24%

Metric

Value

Book value per share

$30.71

Debt / equity

0.02

Long-term assets

$578,000

Long-term liabilities

$103,000

Net cash (debt)

$21M

Net cash / market cap

460.05%

Net cash growth

-38.76%

Net debt / equity

-1.02

Piotroski F-Score

Property, plant and equipment

$547,000

Shareholders' equity

$20.7M

Tangible book value

$20.7M

Tangible book value per share

$30.71

Total assets

$22.7M

Total cash

$21.5M

Total debt

$505,000

Total liabilities

$2M

WACC

10.24%

Metric	Value
Current assets	$22.1M
Current liabilities	$1.9M
Current ratio	11.7
Net working capital	$-889,000
Quick ratio	11.39
Working capital	$20.2M

Metric

Value

Current assets

$22.1M

Current liabilities

$1.9M

Current ratio

11.7

Net working capital

$-889,000

Quick ratio

11.39

Working capital

$20.2M

Metric	Value
Buyback yield / dilution	-14.6%
Dividend yield	0%
Shareholder yield	-14.6%

Metric

Value

Buyback yield / dilution

-14.6%

Dividend yield

Shareholder yield

-14.6%

Metric	Value
150-day SMA	$10.21
1D price change	1.63%
1M price change	-20.99%
1M total return	-20.99%
1W price change	-6.55%
1W total return	-6.55%
1Y price change	-72.82%
1Y return CAGR	-72.85%
1Y total return	-72.82%
20-day SMA	$7.66
200-day SMA	$10.36
3M price change	-35.8%
3M total return	-35.8%
3Y price change	-96.16%
3Y return CAGR	-66.26%
3Y total return	-96.16%
50-day SMA	$9.10
50-day SMA vs 200-day SMA	50under200
52-week high	$26.25
52-week high date	2025-10-29
52-week low	$6.52
52-week low date	2026-10-27
5Y price change	-97.86%
5Y return CAGR	-53.67%
5Y total return	-97.86%
6M price change	-42.53%
6M total return	-42.53%
All-time high	$4,935.01
All-time high date	2018-05-31
All-time low	$6.46
All-time low date	2026-10-28
Average true range (ATR)	$0.72
Average volume	40K
Beta (1Y)	2.35
Beta (2Y)	1.9
Beta (5Y)	1.29
Change from 52-week high	-73.9%
Change from 52-week low	5.06%
Change from all-time high	-99.86%
Change from all-time low	6.04%
Change from open	-4.86%
Day's gap	6.82%
Dollar volume	$309,305
High price	$7.20
Low price	$6.46
Monthly RSI	32.23
Open price	$7.20
Position in 52-week range	52.7%
Previous close	$6.74
Price vs 150-day SMA	-32.89%
Price vs 20-day SMA	-10.55%
Price vs 200-day SMA	-33.91%
Price vs 50-day SMA	-24.73%
Relative volume	1.14
RSI	34.5
Sharpe ratio	-1.06
Sharpe ratio (3Y)	-0.74
Sharpe ratio (5Y)	-0.53
Sortino ratio	-1.33
Sortino ratio (3Y)	-0.88
Sortino ratio (5Y)	-0.63
Volume	45.2K
Weekly RSI	32.04
YTD price change	-38.99%
YTD total return	-38.99%

Metric

Value

150-day SMA

$10.21

1D price change

1.63%

1M price change

-20.99%

1M total return

-20.99%

1W price change

-6.55%

1W total return

-6.55%

1Y price change

-72.82%

1Y return CAGR

-72.85%

1Y total return

-72.82%

20-day SMA

$7.66

200-day SMA

$10.36

3M price change

-35.8%

3M total return

-35.8%

3Y price change

-96.16%

3Y return CAGR

-66.26%

3Y total return

-96.16%

50-day SMA

$9.10

50-day SMA vs 200-day SMA

50under200

52-week high

$26.25

52-week high date

2025-10-29

52-week low

$6.52

52-week low date

2026-10-27

5Y price change

-97.86%

5Y return CAGR

-53.67%

5Y total return

-97.86%

6M price change

-42.53%

6M total return

-42.53%

All-time high

$4,935.01

All-time high date

2018-05-31

All-time low

$6.46

All-time low date

2026-10-28

Average true range (ATR)

$0.72

Average volume

40K

Beta (1Y)

2.35

Beta (2Y)

1.9

Beta (5Y)

1.29

Change from 52-week high

-73.9%

Change from 52-week low

5.06%

Change from all-time high

-99.86%

Change from all-time low

6.04%

Change from open

-4.86%

Day's gap

6.82%

Dollar volume

$309,305

High price

$7.20

Low price

$6.46

Monthly RSI

32.23

Open price

$7.20

Position in 52-week range

52.7%

Previous close

$6.74

Price vs 150-day SMA

-32.89%

Price vs 20-day SMA

-10.55%

Price vs 200-day SMA

-33.91%

Price vs 50-day SMA

-24.73%

Relative volume

1.14

RSI

34.5

Sharpe ratio

-1.06

Sharpe ratio (3Y)

-0.74

Sharpe ratio (5Y)

-0.53

Sortino ratio

-1.33

Sortino ratio (3Y)

-0.88

Sortino ratio (5Y)

-0.63

Volume

45.2K

Weekly RSI

32.04

YTD price change

-38.99%

YTD total return

-38.99%

Metric	Value
Float	590.4K
Float percentage	86.48%
Shares change (QoQ)	2.6%
Shares change (YoY)	14.6%
Shares held by insiders	2.99%
Shares held by institutions	6.52%
Shares outstanding	682.7K
Short % of float	2.29%
Short % of shares	1.98%
Short ratio	0.5 days

Metric

Value

Float

590.4K

Float percentage

86.48%

Shares change (QoQ)

2.6%

Shares change (YoY)

14.6%

Shares held by insiders

2.99%

Shares held by institutions

6.52%

Shares outstanding

682.7K

Short % of float

2.29%

Short % of shares

1.98%

Short ratio

0.5 days

enVVeno Medical Corporation (NVNO)

Price

Financial snapshot

Fair-value bridge

Latest news · NVNO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NVNO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NVNO

Frequently asked questions